GC does need to communicate the details of these s
Post# of 30028
Posted On: 08/01/2014 10:06:10 PM
GC does need to communicate the details of these studies better than he has to date. It's not hard. Keep in mind Lympro V1 has been studied in many more patients. V1 works quite well and has SS numbers in the 90's. This is simply a Bridging Study for V2 and the numbers will be better.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼